# CRH share price today (CRH plc, CRH)

> CRH plc's earnings have grown faster than its share price. Earnings per share grew +9.8% in a year while the price moved −21.5%. CRH · Materials · Building Materials · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/crh

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Mixed, from the last 12 quarters
- Price: $93.53 (−21.5% in a year)
- P/E: 17.6× (higher than 55% of the last 4.6 years)
- Revenue (Jun 2026): $10.8 B (+5.6% on a year ago)
- Profit (Jun 2026): $1.5 B (+13.4% on a year ago)
- Operating margin: 19.0% (+0.2 points on a year ago)
- ROE: 15%, FY25
- ROIC: 9.4%, against a 8.8% cost of capital: +0.6 points

The main question: yearly earnings per share moved +9.8% while the share price moved −21.5%. ## What is the CRH share price today? CRH plc's share price was $93.53 at the close on 3 November 2026. It has been falling for 7 weeks. That is 9.9% below its average price over the last 200 trading days. In the last 52 weeks it traded between $82 and $131, and at that close it sat 24% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 37 weeks running. Over the last 10 years the share price moved +241% while the S&P 500 moved +255%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 20 February 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does CRH pay? CRH plc paid $1.52 per share over the last four reported quarters. The most recent declaration was $0.39 for Jun 2026. At today's price of $93.53 that is a yield of 1.63%, based on dividends already paid, not a forecast. ## Which stock lists is CRH on? CRH is on one of our US lists: S&P 500 companies. [S&P 500 companies](https://www.sectoralpha.in/sp-500-stocks)

## Is CRH profitable? CRH plc earned $1.5 B of net profit in the Jun 2026 quarter, +13.4% on the same quarter a year earlier. Full-year FY25 profit was $3.8 B. Over 4 years profit has grown 9.0% a year on average. That is 14.0% of the quarter's revenue. The same quarter a year earlier earned $1.3 B. 2 of the last 12 reported quarters were loss-making. For the full year, FY25 profit was $3.8 B (+7.6% on the year before). Why profit moved: revenue changed +5.6% on a year earlier and the margin moved +0.2 percentage points. Sales did the work, and the margin was about flat. On average over the last four quarters, profit changed +23.0% and revenue +6.6%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra dollar of revenue adds more to profit. ## How much revenue does CRH make, and is it growing? CRH plc reported $10.8 B of revenue in the Jun 2026 quarter, +5.6% on the same quarter a year earlier. That is the 6th quarter in a row with growth on the year before. Over 4 years it has grown 6.4% a year on average. The last full year, FY25, came in at $37.4 B. The last four reported quarters add to $38.6 B. FY25 revenue was $37.4 B, +5.3% on the year before. Recent pace: the last four quarters grew +6.6% on average, against 6.4% a year over the longer run, so this year is growing at about the same pace as its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +6.3%, against +3.6% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +16.7%, against −0.8% a year (accelerating). ## How much of every $100 of sales does CRH keep? CRH plc's operating margin was 19.0% in the Jun 2026 quarter, 0.2 percentage points higher than the same quarter a year ago. Its latest full-year margin is the highest it has ever reported. Across 5 years it has been between 11.3% and 14.3%. The latest quarter is above every full year in that period. Across 5 years it has been between 11.3% and 14.3%, and FY25's 14.3% is the highest of them. Why the margin moved: operating margin changed +0.2 percentage points on the year while gross margin changed +0.4 points. So the gain came mostly from the gross margin, which means input costs and prices charged. When margins are at a record, every ratio built on profit looks better than usual, so watch whether they hold. ## Is CRH's profit turning into cash? Over the last 3 years, 151% of CRH plc's reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $5.6 B of operating cash against $3.8 B of profit. After $2.7 B of spending on assets, $2.9 B was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does CRH's cash go? CRH plc does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $7.1 B on assets over the last 3 years. Averaged over those years that is 6.3% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $7.1 B over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is CRH's P/E ratio, and how does it compare with its own history? CRH plc's P/E is 17.6×, in the middle of its own history: higher than 55% of past readings. Its usual P/E (the middle reading) is 16.9×, over 4.6 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved +9.8% while the price moved −21.5%. Earnings did better than the price, which pulled the multiple down within its own range. Where the price move came from: over 3 years the price moved +18.0% a year; about +7.5% a year came from earnings growth and about +10.5 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is about average against its own past, so the earnings trend underneath matters more than the multiple. ## Is the CRH business getting better or worse? CRH plc's business is giving mixed signals. Growth has been steadily positive, but ROCE at 11.6% is below the 15% level needed to call it steady growth. This is based on 12 quarters of 4 measures. Why it matters: when the lines disagree, each line above matters more than any single label. ## How much does CRH earn on its capital? CRH plc earned a ROE of 15% in FY25. That is up from a low of 13% in FY21. Its return on capital used (ROIC) is 0.6 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 10.1% net margin and 0.64× asset turnover (sales divided by assets). Why the return is what it is (FY25): a 10.1% net margin × 0.64× asset turnover × 2.29× leverage (assets divided by equity) ≈ 14.8% on equity. The margin does its share; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: 9.4% − 8.8% = +0.6 percentage points. The 8.8% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Positive but thin: it creates value with little room for error. The 9.4% ROIC above is the latest reading, as reported. The yearly chart below shows FY25 at 11.1%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does CRH have too much debt? CRH plc has total debt of $19.8 B against shareholder equity of $25.5 B as of Jun 2026, so its debt is 0.78× its equity. Year by year, that ratio went from 0.58 in FY21 to 0.77 in FY25. Keep that borrowing in mind when reading the returns on this page. ## What is the CRH shareholding pattern? We have no ownership or short-position figures for CRH plc, so this section says so rather than fill the gap. At normal trading volumes, closing those positions would take about 2.3 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. ## How far is CRH from balance-sheet trouble? For CRH plc, the Z-score is 2.92. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the grey area between the two. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 2.92 is in the grey area, neither clearly safe nor clearly in trouble. ## How does CRH rank in its industry? 54.3 out of 100, rank 5 of 14 in Building Materials, with 85% of the evidence available. CRH plc scores 54.3 out of 100 against the 14 companies it is compared with in Building Materials, ranking 5. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 20.5 + 12.3 + 13.2 + 8.3 = 54.3. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is CRH compared with? CRH ranks 5 of 14 Building Materials companies on the 4-Factor Sector Score, with 54.3 out of 100. 1. [Cementos Pacasmayo S.A.A.](https://www.sectoralpha.in/us/stocks/cpac) CPAC · breaking out · Most evidence points up · 85% evidence 78.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.0/35 · Revenue 10.9% · Profit -0.5% · Operating margin change 5.7 points · 95% evidence Capital efficiency 20.4/25 · ROCE 22.3% · Operating margin 24.4% · 76% evidence Valuation 15.8/20 · P/E 16.2× · PEG 0.43 · 65% evidence Relative strength 17.6/20 · Lead over its industry 24.1% · Lead over S&P 500 11.8% · 1 year 73.8% · 100% evidence · 7 of 12 weeks ahead Exact sum: 25 + 20.4 + 15.8 + 17.6 = 78.8 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [United States Lime & Minerals, Inc.](https://www.sectoralpha.in/us/stocks/uslm) USLM · turning · Evidence leans up · 85% evidence 61.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.5/35 · Revenue 7.1% · Profit 8.8% · Operating margin change 2 points · 95% evidence Capital efficiency 20.9/25 · ROCE 21.8% · Operating margin 41% · 76% evidence Valuation 5.1/20 · P/E 22.3× · PEG 3.13 · 65% evidence Relative strength 17.4/20 · Lead over its industry 10.1% · Lead over S&P 500 -1.7% · 1 year 4.6% · 100% evidence · 3 of 12 weeks ahead Exact sum: 18.5 + 20.9 + 5.1 + 17.4 = 61.9 · What this means: A strong business with a high valuation: it would need rising earnings, or a lower multiple, to score better on value. 3. [Martin Marietta Materials, Inc.](https://www.sectoralpha.in/us/stocks/mlm) MLM · turning · Evidence leans up · 85% evidence 60.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.7/35 · Revenue 14.8% · Profit 100% · Operating margin change -5.9 points · 95% evidence Capital efficiency 10.3/25 · ROCE 7.3% · Operating margin 20.2% · 76% evidence Valuation 15.9/20 · P/E 14.1× · PEG 0.74 · 65% evidence Relative strength 12.0/20 · Lead over its industry -0.8% · Lead over S&P 500 -11.9% · 1 year -11% · 100% evidence · 0 of 12 weeks ahead Exact sum: 22.7 + 10.3 + 15.9 + 12 = 60.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [Vulcan Materials Company](https://www.sectoralpha.in/us/stocks/vmc) VMC · turning · Evidence leans up · 85% evidence 60.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.4/35 · Revenue 6.9% · Profit 17.4% · Operating margin change -0.7 points · 95% evidence Capital efficiency 13.7/25 · ROCE 10.6% · Operating margin 21.6% · 76% evidence Valuation 8.4/20 · P/E 34.3× · PEG 1.88 · 65% evidence Relative strength 15.9/20 · Lead over its industry 7.1% · Lead over S&P 500 -4.6% · 1 year -0.9% · 100% evidence · 0 of 12 weeks ahead Exact sum: 22.4 + 13.7 + 8.4 + 15.9 = 60.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. CRH plc this page CRH · basing · Evidence leans up · 85% evidence 54.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.5/35 · Revenue 6.3% · Profit 16.7% · Operating margin change 0.2 points · 95% evidence Capital efficiency 12.3/25 · ROCE 11.2% · Operating margin 19% · 76% evidence Valuation 13.2/20 · P/E 18.7× · PEG 1.02 · 65% evidence Relative strength 8.3/20 · Lead over its industry -6.7% · Lead over S&P 500 -17.4% · 1 year -17.2% · 100% evidence · 0 of 12 weeks ahead Exact sum: 20.5 + 12.3 + 13.2 + 8.3 = 54.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Tecnoglass Inc.](https://www.sectoralpha.in/us/stocks/tgls) TGLS · basing · Evidence leans up · 85% evidence 51.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 9.7/35 · Revenue 9.7% · Profit -29% · Operating margin change -11.8 points · 95% evidence Capital efficiency 16.7/25 · ROCE 18.2% · Operating margin 12.4% · 76% evidence Valuation 14.9/20 · P/E 16× · PEG 0.85 · 65% evidence Relative strength 9.7/20 · Lead over its industry -4.6% · Lead over S&P 500 -15.4% · 1 year -20.3% · 100% evidence · 0 of 12 weeks ahead Exact sum: 9.7 + 16.7 + 14.9 + 9.7 = 51 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 7. [Eagle Materials Inc.](https://www.sectoralpha.in/us/stocks/exp) EXP · basing · Evidence leans down · 85% evidence 49.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 8.8/35 · Revenue 1.7% · Profit -11.3% · Operating margin change -4.3 points · 95% evidence Capital efficiency 17.4/25 · ROCE 14.9% · Operating margin 21.7% · 76% evidence Valuation 10.5/20 · P/E 17.3× · PEG 1.87 · 65% evidence Relative strength 12.4/20 · Lead over its industry 0.3% · Lead over S&P 500 -10.8% · 1 year -6.9% · 100% evidence · 0 of 12 weeks ahead Exact sum: 8.8 + 17.4 + 10.5 + 12.4 = 49.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [CEMEX, S.A.B. de C.V.](https://www.sectoralpha.in/us/stocks/cx) CX · basing · Evidence leans down · 75% evidence 46.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.8/35 · Revenue 9.6% · Profit -67.1% · Operating margin change 3.3 points · 95% evidence Capital efficiency 9.6/25 · ROCE 9.8% · Operating margin 13.7% · 76% evidence Valuation 8.7/20 · P/E 36.1× · PEG n/a · 15% evidence Relative strength 7.9/20 · Lead over its industry -2.1% · Lead over S&P 500 -12.8% · 1 year 3.8% · 100% evidence · 0 of 12 weeks ahead Exact sum: 19.8 + 9.6 + 8.7 + 7.9 = 46 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Amrize AG](https://www.sectoralpha.in/us/stocks/amrz) AMRZ · basing · Evidence leans down · 75% evidence 40.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 15.4/35 · Revenue 5.1% · Profit 4.2% · Operating margin change -0.4 points · 95% evidence Capital efficiency 9.9/25 · ROCE 9.4% · Operating margin 20.5% · 76% evidence Valuation 9.4/20 · P/E 24.1× · PEG n/a · 15% evidence Relative strength 6.0/20 · Lead over its industry -11.7% · Lead over S&P 500 -21.9% · 1 year -15.1% · 100% evidence · 0 of 12 weeks ahead Exact sum: 15.4 + 9.9 + 9.4 + 6 = 40.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [James Hardie Industries plc](https://www.sectoralpha.in/us/stocks/jhx) JHX · quiet · Evidence leans down · 85% evidence 39.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.7/35 · Revenue 42.9% · Profit -56% · Operating margin change -2.6 points · 95% evidence Capital efficiency 8.1/25 · ROCE 6.8% · Operating margin 16.1% · 76% evidence Valuation 5.5/20 · P/E 105.2× · PEG 2.6 · 65% evidence Relative strength 13.6/20 · Lead over its industry 22.2% · Lead over S&P 500 10% · 1 year 56.8% · 100% evidence · 4 of 12 weeks ahead Exact sum: 12.7 + 8.1 + 5.5 + 13.6 = 39.9 · What this means: Relative strength against the index is 10%, and revenue and profit growth are weak. 11. [Titan America SA](https://www.sectoralpha.in/us/stocks/ttam) TTAM · basing · Evidence leans down · 85% evidence 37.8 out of 100 Growth Capital Valuation Relative
12. [Knife River Corporation](https://www.sectoralpha.in/us/stocks/knf) KNF · basing · Most evidence points down · 85% evidence 30.5 out of 100 Growth Capital Valuation Relative
13. [Suncrete, Inc.](https://www.sectoralpha.in/us/stocks/rmix) RMIX · basing · Most evidence points down · 67% evidence 27.3 out of 100 Growth Capital Valuation Relative
14. Smith-Midland Corporation SMID · basing · Most evidence points down · 85% evidence 25.7 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Jun 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Building Materials](https://www.sectoralpha.in/us/sectors/building-materials), all 14 compared on one page. ## Which companies are close to CRH in size? CRH is the largest of 14 Building Materials companies on Sector Alpha by market value (scores of 3 November 2026). It is the largest. Just below it: Martin Marietta Materials, Inc., Vulcan Materials Company, Amrize AG, James Hardie Industries plc, CEMEX, S.A.B. de C.V. and Eagle Materials Inc. ### Building Materials companies close in size

1. CRH plc $62.2 billion
2. [Martin Marietta Materials, Inc.](https://www.sectoralpha.in/us/stocks/mlm) $38.6 billion
3. [Vulcan Materials Company](https://www.sectoralpha.in/us/stocks/vmc) $36.5 billion
4. [Amrize AG](https://www.sectoralpha.in/us/stocks/amrz) $22.1 billion
5. [James Hardie Industries plc](https://www.sectoralpha.in/us/stocks/jhx) $15.6 billion
6. [CEMEX, S.A.B. de C.V.](https://www.sectoralpha.in/us/stocks/cx) $15.5 billion
7. [Eagle Materials Inc.](https://www.sectoralpha.in/us/stocks/exp) $5.9 billion

[All 14 Building Materials companies, largest first](https://www.sectoralpha.in/us/sectors/building-materials#all-companies)

### Companies close in size in other industries

1. [Public Storage](https://www.sectoralpha.in/us/stocks/psa) $64.7 billion · REIT - Industrial
2. [Cencora, Inc.](https://www.sectoralpha.in/us/stocks/cor) $64.5 billion · Medical Distribution
3. CRH plc $64.3 billion
4. [Boston Scientific Corporation](https://www.sectoralpha.in/us/stocks/bsx) $64.2 billion · Medical Devices
5. [MetLife, Inc.](https://www.sectoralpha.in/us/stocks/met) $64.1 billion · Insurance - Life

## What else do people ask about CRH? ### What were CRH's latest quarterly results? CRH plc reported revenue of $10.8 B and net profit of $1.5 B for the Jun 2026 quarter. Revenue rose 5.6% and profit rose 13.4% compared with a year earlier. Earnings per share were $2.21. The operating margin was 19.0%, 0.2 percentage points higher than a year earlier (as of 3 November 2026). ### What is CRH's market cap? CRH plc's market capitalisation is $62.2 B at a stock price of $93.53. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is CRH performing? CRH plc's share price has been falling for 7 weeks. In its latest quarter, revenue rose 5.6% and profit rose 13.4% compared with a year earlier. Over the past 13 weeks it has done worse than the S&P 500, for 37 weeks running (as of 3 November 2026). ### Will CRH's stock price go up? This page does not forecast CRH plc's stock price. What it shows instead: the stock price is $93.53, and it has been falling for 7 weeks. Its P/E of 17.6× is higher than 55% of its own last 5 years (as of 3 November 2026). ### Does CRH have too much debt? CRH plc has a moderate amount of debt: its debt is 0.82× its equity. A year-by-year history of its borrowings is not in our data, so this uses the latest reading. Keep that borrowing in mind when reading the returns on this page (as of 3 November 2026). ### Where is CRH in its business cycle? CRH plc's FY25 operating margin was 14.3%, against a 5-year range of 11.3% to 14.3%: the top of its range, a record year. When profit is at a record, every ratio looks better than usual, and the story depends on margins staying high. The latest quarter was 19.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the CRH story? The main question: yearly earnings per share moved +9.8% while the share price moved −21.5%. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is CRH a stock worth studying right now? What the numbers show: CRH plc's earnings have grown faster than its share price. Earnings per share grew +9.8% in a year while the price moved −21.5%. The main open question: whether the price catches up with earnings that have already grown. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ## Lists

- S&P 500 companies: https://www.sectoralpha.in/sp-500-stocks

This is research, not advice. We’re not SEBI-registered.